Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Single-blind, Randomized, Controlled Study in Healthy Kenyan Infants to Assess the Immunogenicity and Safety of Beijing TiantanBio Liquid Bivalent Oral Poliomyelitis Vaccine (bOPV) in Comparison to a WHO Prequalified Comparator bOPV

NCT02434770 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT02434770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02434770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Single-blind, Randomized, Controlled Study in Healthy Kenyan Infants to Assess the Immunogenicity and Safety of Beijing TiantanBio Liquid Bivalent Oral Poliomyelitis Vaccine (bOPV) in Comparison to a WHO Prequalified Comparator bOPV
Lead sponsor
PATH
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2015
Completion date
June 17, 2016
Enrollment
750 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

poliomyelitis